FDA Says Moderna Exposed Participants, Age 65 And Over, To Increased Risk Of Severe Illness By Giving Them A Substandard Of Care Against The Recommendation Of FDA Career Scientists
Moderna +2.69%
Moderna MRNA | 54.26 | +2.69% |
-Reuters Citing Statement
